Upright CT for lung cancer therapy planning used at Chicago Proton Center

The Northwestern Medicine Chicago Proton Center will be the first proton center in the U.S. to use P-Cure new P-ARTIS CT on patients being treated for lung cancer. Traditionally, patients lie flat on their backs during CT... read more

Upright CT for lung cancer therapy planning used at Chicago Proton Center

Quality of Outpatient Care Delivered to Adults in USA

This cross-sectional survey study measures changes in outpatient quality and patient experience in the United States from 2002 to 2013 to determine whether efforts to improve outpatient quality have been successful. Three... read more

Quality of Outpatient Care Delivered to Adults in USA

Drugs Don’t Cut Trastuzumab-Tied Left Ventricular Remodeling

The researchers found that the drugs were well tolerated, with no serious adverse events reported. The indexed left ventricular end diastolic volume increased in patients treated with perindopril, bisoprolol, and placebo... read more

Drugs Don’t Cut Trastuzumab-Tied Left Ventricular Remodeling

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

Having a history of cancer does not worsen outcomes for patients with STEMI who undergo primary PCI and should not be a barrier to revascularization and optimal therapy.... read more

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

Value of Expedited Drug Approvals for Cancer Care

This study examines potential benefits of cancer drugs approved by the FDA on the basis of surrogate endpoints.... read more

Value of Expedited Drug Approvals for Cancer Care

USPSTF: Don’t Screen Asymptomatic Adults for Thyroid Cancer

After reviewing studies on the benefits and harms of screening and treatment for thyroid cancer, a newly released U.S. Preventive Services Task Force draft statement recommends against screening asymptomatic adults for the... read more

USPSTF: Don’t Screen Asymptomatic Adults for Thyroid Cancer

Successfully treating genetically determined autoimmune enteritis

Using targeted immunotherapy, doctors have succeeded in curing a type of autoimmune enteritis caused by a recently discovered genetic mutation.... read more

Successfully treating genetically determined autoimmune enteritis

New Cytokine Approach is Synergistic With Checkpoint Inhibitors

Among the new agents currently being explored in clinical trials, NKTR-214 stands out as a new cytokine therapy approach that could show additive benefit when combined with checkpoint inhibitors. ... read more

New Cytokine Approach is Synergistic With Checkpoint Inhibitors

CDC estimates preventable deaths from 5 leading causes

The federal Centers for Disease Control and Prevention released data naming the five leading causes of death among Americans under age 80 for 2014.... read more

CDC estimates preventable deaths from 5 leading causes

New discovery paves way for pancreatic cancer treatment

Patients suffering from pancreatic cancer may soon face better treatment options due to the latest discovery by Dr. Reginald Hill, who's research focuses on drugs that are already approved by the FDA.... read more

New discovery paves way for pancreatic cancer treatment

Spread of cancer linked to cell metabolism, study shows

Cellular metabolism in white blood cells can be manipulated to prevent the spread of cancer, VIB and KU Leuven researchers suggest in a new study.... read more

Spread of cancer linked to cell metabolism, study shows

Molecular machines generate Nobel award for European researchers

Three EU-funded researchers have been awarded a share of the 2016 Nobel Prize in Chemistry for developing molecular machines including a tiny lift, artificial muscles and miniscule motors, that are a thousand times thinner... read more

Molecular machines generate Nobel award for European researchers

New tool helps measure how costs of care impact cancer patients

For many patients, the uncertainty and stress that can come with cancer treatment is compounded by what is now known as "financial toxicity", the anxiety and distress that follow health care and medication expenses, often... read more

New tool helps measure how costs of care impact cancer patients

Frontline PARP inhibitor shrinks tumors in BRCA-positive breast patients

All 13 newly diagnosed breast cancer patients with BRCA mutations had their tumors shrink significantly when treated with a PARP inhibitor ahead of frontline presurgical chemotherapy in a pilot study at The University of... read more

Frontline PARP inhibitor shrinks tumors in BRCA-positive breast patients

New Ecosystem Test Strongly Predicts Ovarian Cancer Survival

Assessing the cell ecosystems at sites where ovarian cancer has spread round the body strongly predicts the chances of surviving from the disease, a new study reports. ... read more

New Ecosystem Test Strongly Predicts Ovarian Cancer Survival

HDAC inhibitors show promise against cancer stem cells

A group of researchers, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has shown that histone deacetylase (HDAC) inhibitors have the potential to eliminate... read more

HDAC inhibitors show promise against cancer stem cells

HPV Vaccine More Effective Than Thought

The vaccine against human papillomavirus (HPV) infection, which doctors believe causes most cases of cervical cancer, appears even more effective than believed, a new study finds.... read more

HPV Vaccine More Effective Than Thought

A Simple Breath Test Can Spot Pneumonia And Lower Antibiotic Overuse

A simple test could be all physicians need to determine if they need to prescribe antibiotics.... read more

A Simple Breath Test Can Spot Pneumonia And Lower Antibiotic Overuse

Bifunctional drug could treat tumors resistant to current mTOR inhibitors

The first known bifunctional inhibitor for the mechanistic target of rapamycin (mTOR) protein was developed to overcome current known mechanisms of tumor resistance to mTOR inhibitors.... read more

Bifunctional drug could treat tumors resistant to current mTOR inhibitors

Dramatic remissions seen in immunotherapy trial of blood cancer patients

Many patients with advanced blood cancers who are receiving experimental, "living" immunotherapy as part of a clinical trial are experiencing sustained remissions, according to preliminary results of the ongoing... read more

Dramatic remissions seen in immunotherapy trial of blood cancer patients